Jenburkt Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 48.98 | 44.84 | 47.64 |
| Operating Expense | 34.33 | 35.59 | 32.45 |
| Net Profit | 10.85 | 5.93 | 10.16 |
| Net Profit Margin | 22.15% | 13.22% | 21.33% |
| Earning Per Share | 24.58 | 13.44 | 23.03 |
| EBIDTA | 15.43 | 9.88 | 15.01 |
| Effective Tax Rate | 24.85% | 32.47% | 26.35% |
Particulars
Mar 2026
Revenue48.98
Operating Expense34.33
Net Profit10.85
Net Profit Margin22.15
Earning Per Share24.58
EBIDTA15.43
Effective Tax Rate24.85
